Bayer AG

Greenhouse gas emissions & sustainability report data

📊 Latest report period: 2020🗂️ Report periods on file: 2020, 2019

In its 2020 reporting, Bayer AG disclosed greenhouse gas emissions of 3.58 million tCO2e. By scope: Scope 1: 2.01 million tCO2e; Scope 2: 1.57 million tCO2e; Scope 3: 8.86 million tCO2e. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

💨
GHG Emissions
3.58 million tCO2e
2020
⚡
Renewable Energy
6.1%
of total energy
💧
Water Usage
57 million m3
2020
♻️
Waste
937.0K tons
2020
⚙️
Energy Use
35.9K MWh
2020

📊 Emissions by Scope (2020)

ScopeWhat it coversReported value
Scope 1Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions).2.01 million tCO2e
Scope 2Indirect emissions from purchased electricity, steam, heat and cooling.1.57 million tCO2e
Scope 3Other indirect emissions across the value chain (purchased goods, business travel, use of sold products, etc.).8.86 million tCO2e

New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.

📈 Emissions by Report Period

Report periodHeadline emissions figure reported
20203.58 million tCO2e
201912-15m tons/year (CO2e)

Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.

✅ Reported Environmental Achievements

🎯 Climate & Sustainability Targets

📅 Medium-term

  • Reduce Scope 1 & 2 greenhouse gas emissions by 42% by the end of 2029
  • Reduce Scope 3 greenhouse gas emissions by 12.3% by 2029
  • Achieve climate neutrality in own operations by 2030
  • Empower 100 million smallholder farmers in low- and middle-income countries by 2030
  • Provide access to modern contraception for 100 million women in low- and middle-income countries by 2030

🔭 Long-term

  • Reach net zero emissions in entire value chain by 2050

🌱 ESG Focus Areas

Climate and environmental protectionAccess to health careSustainable food supplyProduct stewardshipBusiness ethicsInnovationHuman rights

⚠️ Challenges & Risks +

  • COVID-19 pandemic impacting business activities (reduced demand, postponed treatments, supply chain disruptions)
  • Challenging market environment and negative currency effects reducing growth expectations in agriculture
  • Glyphosate, PCB, dicamba, and Essure™ litigations
  • Increased competition in seed and crop protection industry
  • Regulatory changes impacting product sales and use
  • Risks associated with innovation (new therapy platforms, business model development)
  • Difficulties in recruiting and retaining specialized employees
  • Risks related to IT systems (cyberattacks, data breaches)
  • Liquidity and credit risks
  • Fluctuations in currency exchange rates, interest rates, and commodity prices

📋 Report Information

Reporting Period: 2020
Frameworks: GRI Standards
Assurance: Deloitte GmbH Wirtschaftsprüfungsgesellschaft